Antibody data
- Antibody Data
 - Antigen structure
 - References [3]
 - Comments [0]
 - Validations
 - Western blot [2]
 - ELISA [1]
 - Immunohistochemistry [1]
 
Submit
Validation data
Reference
Comment
Report error
- Product number
 - H00010327-M01 - Provider product page

 - Provider
 - Abnova Corporation
 - Proper citation
 - Abnova Corporation Cat#H00010327-M01, RRID:AB_425840
 - Product name
 - AKR1A1 monoclonal antibody (M01), clone 1A11-2A4
 - Antibody type
 - Monoclonal
 - Description
 - Mouse monoclonal antibody raised against a full length recombinant AKR1A1.
 - Antigen sequence
 MAASCVLLHTGQKMPLIGLGTWKSEPGQVKAAVKY
ALSVGYRHIDCAAIYGNEPEIGEALKEDVGPGKAV
PREELFVTSKLWNTKHHPEDVEPALRKTLADLQLE
YLDLYLMHWPYAFERGDNPFPKNADGTICYDSTHY
KETWKALEALVAKGLVQALGLSNFNSRQIDDILSV
ASVRPAVLQVECHPYLAQNELIAHCQARGLEVTAY
SPLGSSDRAWRDPDEPVLLEEPVVLALAEKYGRSP
AQILLRWQVQRKVICIPKSITPSRILQNIKVFDFT
FSPEEMKQLNALNKNWRYIVPMLTVDGKRVPRDAG
HPLYPFNDPY- Isotype
 - IgG
 - Antibody clone number
 - 1A11-2A4
 - Storage
 - Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing.
 
Submitted references		Two allelic variants of aldo-keto reductase 1A1 exhibit reduced in vitro metabolism of daunorubicin.
				
Mapping of phosphorylation-dependent anti-tau monoclonal antibodies in immunoblots using human tau-constructs synthesized by native chemical ligation.
				
Aldo-keto reductase 1C2 fails to metabolize doxorubicin and daunorubicin in vitro.
				
		
	
			Bains OS, Takahashi RH, Pfeifer TA, Grigliatti TA, Reid RE, Riggs KW
Drug metabolism and disposition: the biological fate of chemicals 2008 May;36(5):904-10
		Drug metabolism and disposition: the biological fate of chemicals 2008 May;36(5):904-10
Mapping of phosphorylation-dependent anti-tau monoclonal antibodies in immunoblots using human tau-constructs synthesized by native chemical ligation.
			Singer D, Herth N, Kuhlmann J, Holland-Nell K, Beck-Sickinger AG, Hoffmann R
Biochemical and biophysical research communications 2008 Mar 7;367(2):318-22
		Biochemical and biophysical research communications 2008 Mar 7;367(2):318-22
Aldo-keto reductase 1C2 fails to metabolize doxorubicin and daunorubicin in vitro.
			Takahashi RH, Bains OS, Pfeifer TA, Grigliatti TA, Reid RE, Riggs KW
Drug metabolism and disposition: the biological fate of chemicals 2008 Jun;36(6):991-4
		Drug metabolism and disposition: the biological fate of chemicals 2008 Jun;36(6):991-4
				No comments: Submit comment	
	
			
							
					Supportive validation
					
									
				
				- Submitted by
 - Abnova Corporation (provider)
 - Main image
 
- Experimental details
 - AKR1A1 monoclonal antibody (M01), clone 1A11-2A4 Western Blot analysis of AKR1A1 expression in HL-60 ( Cat # L014V1 ).
 
- Submitted by
 - Abnova Corporation (provider)
 - Main image
 
- Experimental details
 - Western Blot analysis of AKR1A1 expression in transfected 293T cell line by AKR1A1 monoclonal antibody (M01), clone 1A11-2A4.Lane 1: AKR1A1 transfected lysate(36.6 KDa).Lane 2: Non-transfected lysate.
 
							
					Supportive validation
					
									
				
				- Submitted by
 - Abnova Corporation (provider)
 - Main image
 
- Experimental details
 - Detection limit for recombinant GST tagged AKR1A1 is approximately 0.1ng/ml as a capture antibody.
 - Validation comment
 - Sandwich ELISA (Recombinant protein)
 - Protocol
 - Protocol
 
							
					Supportive validation
					
									
				
		- Submitted by
 - Abnova Corporation (provider)
 - Main image
 
- Experimental details
 - Immunoperoxidase of monoclonal antibody to AKR1A1 on formalin-fixed paraffin-embedded human tonsil. [antibody concentration 0.75 ug/ml]
 - Validation comment
 - Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)
 - Protocol
 - Protocol